Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 3146 (MIR3146) is a human microRNA, a small non-coding RNA molecule that functions primarily in the RNA-induced silencing complex (RISC) to regulate gene expression at the post-transcriptional level. Like other microRNAs, its biogenesis involves transcription as a primary miRNA (pri-miRNA), processing by the Drosha-DGCR8 complex in the nucleus, export to the cytoplasm, and further cleavage by Dicer to produce the mature miRNA, which then associates with Argonaute proteins to guide sequence-specific silencing of target mRNAs[1][4]. As of the current literature and available databases, there is no evidence that MIR3146 is a validated therapeutic target or plays a unique, disease-specific role. Its biological characteristics and mechanisms are expected to follow those of the general microRNA family, contributing to gene regulatory networks in human cells[1][4].
Not applicable, as no specific drugs acting on this microRNA have been described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3146 (MIR3146).